Stock Research for PSTI

PSTI
Current Price

$1.3600


Latest Update: 2018-02-16 16:00:00

High
$ 1.3600
Low
$ 1.3600
Close
$ 1.3600
Volume
300
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

PSTI Stock Chart & Research Data

The PSTI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PSTI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


PSTI Due diligence Resources & Stock Charts

The PSTI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PSTI Detailed Price Forecast - CNN Money CNN View PSTI Detailed Summary - Google Finance
Yahoo View PSTI Detailed Summary - Yahoo! Finance Zacks View PSTI Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View PSTI Trends & Analysis - Trade-Ideas Barrons View PSTI Major Holders - Barrons
NASDAQ View PSTI Call Transcripts - NASDAQ Seeking View PSTI Breaking News & Analysis - Seeking Alpha
Spotlight View PSTI Annual Report - CompanySpotlight.com OTC Report View PSTI OTC Short Report - OTCShortReport.com
TradeKing View PSTI Fundamentals - TradeKing Charts View PSTI SEC Filings - Bar Chart
WSJ View Historical Prices for PSTI - The WSJ Morningstar View Performance/Total Return for PSTI - Morningstar
MarketWatch View the Analyst Estimates for PSTI - MarketWatch CNBC View the Earnings History for PSTI - CNBC
StockMarketWatch View the PSTI Earnings - StockMarketWatch MacroAxis View PSTI Buy or Sell Recommendations - MacroAxis
Bullish View the PSTI Bullish Patterns - American Bulls Short Pains View PSTI Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View PSTI Stock Mentions - StockTwits PennyStocks View PSTI Stock Mentions - PennyStockTweets
Twitter View PSTI Stock Mentions - Twitter Invest Hub View PSTI Investment Forum News - Investor Hub
Yahoo View PSTI Stock Mentions - Yahoo! Message Board Seeking Alpha View PSTI Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for PSTI - SECform4.com Insider Cow View Insider Transactions for PSTI - Insider Cow
CNBC View PSTI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PSTI - OTC Markets
Yahoo View Insider Transactions for PSTI - Yahoo! Finance NASDAQ View Institutional Holdings for PSTI - NASDAQ


Stock Charts

FinViz View PSTI Stock Insight & Charts - FinViz.com StockCharts View PSTI Investment Charts - StockCharts.com
BarChart View PSTI Stock Overview & Charts - BarChart Trading View View PSTI User Generated Charts - Trading View


Latest Financial News for PSTI

What You Must Know About Pluristem Therapeutics Inc’s (NASDAQ:PSTI) Major Investors
Posted on Thursday February 15, 2018

I am going to take a deep dive into Pluristem Therapeutics Inc’s (NASDAQ:PSTI) most recent ownership structure, not a frequent subject of discussion among individual investors. Ownership structure has beenRead More...


Pluristem Issues Letter to Shareholders
Posted on Wednesday February 07, 2018

HAIFA, Israel, Feb. 07, 2018-- Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today reported financial results for the second quarter of fiscal 2018 ended December ...


N.Korea threats spur U.S. search for new radiation therapies
Posted on Wednesday January 31, 2018

The escalating threat of a potential nuclear war between North Korea and the United States has led the Department of Defense to join hands with a clutch of companies in developing more effective medical treatments for acute radiation syndrome. The hostility between the two nations reached a new height last November after Pyongyang fired an intercontinental ballistic missile capable of reaching the U.S. mainland. The DoD's budget allocated $3.9 million of its total funding to develop such medical countermeasures in 2018, an increase of $600,000 from a year ago.


Wired News – Pluristem’s PLX Cells Demonstrated Inhibition of Cancer Cell Growth in Peer-Reviewed Article
Posted on Wednesday January 17, 2018

Stock Monitor: CEL-SCI Post Earnings Reporting LONDON, UK / ACCESSWIRE / January 17, 2018 / Active-Investors.com has just released a free research report on Pluristem Therapeutics Inc. (NASDAQ: PSTI ). ...


Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Pluristem ...
Dispatch Tribunal - Nov 25, 2017
Pluristem Therapeutics earned a media sentiment score of 0.21 on Accern's scale. Accern also gave news coverage about the biotechnology company an impact score of 45.8652058164531 out of 100, indicating that recent news coverage is somewhat unlikely to ...

Pluristem - Hidden Treasures And Sudden Catalysts
Seeking Alpha - Feb 8, 2018
Pluristem primarily utilizes two different placenta-derived cell products (PDX-PAD and PLX-R18), which look to address a wide collection of therapeutic needs. Its lead product indications are Critical Limb Ischemia [CLI], Hip Fracture recovery and ...

Pluristem Therapeutics Inc.: A Biotech Company Inspired By Life
Seeking Alpha - Sep 14, 2017
Pluristem announced two new patents by the Hong Kong Patents Registry on Sept 13, 2017. This article looks at this company and its pipeline.
Is Pluristem Therapeutics Inc. (PSTI) Worth Significant Investment? - StockNewsGazette

February Insights Into Healthcare Stocks: Pluristem Therapeutics Inc (NASDAQ:PSTI)
Simply Wall St - Feb 16, 2018
Pluristem Therapeutics Inc (NASDAQ:PSTI), a US$149.73M small-cap, is a healthcare company operating in an industry, which has experienced tailwinds from issues such as higher demand driven by an aging population and the increasing prevalence of ...
Pluristem Therapeutics (NASDAQ:PSTI) Given Coverage Optimism Score of 0.17 - StockNewsTimes
The Pluristem Therapeutics, Inc. (PSTI) Trading 0.6% Higher - BangaloreWeekly

Enter a stock symbol to view the stock details.